Soteropoulos Paula bought DNTH
March 24, 2026 · Form 4 insider transaction
Soteropoulos Paula bought 27,594 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $232.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,594
Price
$8.44
Total value
$232.9K
InsiderSoteropoulos Paula
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 24, 2026
Filing dateMarch 26, 2026
Shares owned after27,594
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.